Trinity Biotech TRIB
NASDAQ TRIB
$10.91 -0.10 (-0.86%)
At close: Aug 20, 2026 · 10:55 AM UTC

Trinity Biotech (TRIB) Operating Interest Expenses (2015 - 2016)

Trinity Biotech (TRIB) posted Operating Interest Expenses of -$180000.0 for Q3 2016, down 0.56% sequentially from -$179000.0 in Q2 2016, and up 13.46% YoY from -$158644.1 in Q4 2015.

Trinity Biotech (TRIB) Operating Interest Expenses (2015 - 2016) Analysis & Trends

Trinity Biotech has reported Operating Interest Expenses for 2 years, with the latest figure at -$180000.0 in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Interest Expenses (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn -
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn -
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn -
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn -
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn -
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn -
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn -
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn -
10 Trinity Biotech 6.76 Mn 1.62 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2016 -180,000.00
Sep 30, 2016 -180,000.00
Jun 30, 2016 -179,000.00
Jun 30, 2016 -179,000.00
Sep 30, 2015 -208,000.00
Sep 30, 2015 -208,000.00
Jun 30, 2015 -172,000.00
Jun 30, 2015 -172,000.00